1. Home
  2. JFU vs NMTC Comparison

JFU vs NMTC Comparison

Compare JFU & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 9F Inc.

JFU

9F Inc.

HOLD

Current Price

$3.08

Market Cap

46.7M

Sector

Finance

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$3.61

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFU
NMTC
Founded
2006
2009
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.7M
39.5M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
JFU
NMTC
Price
$3.08
$3.61
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.90
AVG Volume (30 Days)
7.2K
33.2K
Earning Date
12-09-2022
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.43
EPS
N/A
N/A
Revenue
N/A
$9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$31.90
P/E Ratio
$1.43
N/A
Revenue Growth
N/A
163.47
52 Week Low
$1.25
$0.55
52 Week High
$9.48
$5.40

Technical Indicators

Market Signals
Indicator
JFU
NMTC
Relative Strength Index (RSI) 41.97 43.67
Support Level $2.65 $0.69
Resistance Level $4.79 $4.87
Average True Range (ATR) 0.47 0.37
MACD -0.07 -0.20
Stochastic Oscillator 7.07 0.83

Price Performance

Historical Comparison
JFU
NMTC

About JFU 9F Inc.

9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: